Of note, ATPB may also exist on the external surface of the cell membrane as ectopic ATP synthase, where it has been indicated as a target marker for tumor therapy [103], while ATP23 was observed in a TCGA (The Cancer Genome Atlas) GBM cohort, in which patients showed a significant decrease in overall survival (OS) [104]. This evidence concerns the gene ATP23 and glioblastoma.